Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis responds to the second Hindenburg Research report. Scorsis highlights the self-interest of short sellers as well as the many inaccurate statements in the report in defense of Liberty Health’s practices. Scorsis clears up a misunderstanding about an early stage private placement, in which shares were sold at $0.01, by noting that those shares became tradeable over a year ago and won’t cause future downward pressure on the company’s stock. Liberty Health had a strong quarter, reporting a 45 percent increase in earnings and a patient load growth of 46 percent. Liberty Health will open another 7 stores by February, bringing its total number of dispensaries in Florida to 14 by the end of Q1 2019.
Liberty Health Sciences Inc CEO George Scorsis on Acquiring US Cannabis Companies
Liberty Health Sciences CEO George Scorsis, Dmitry Zaytsev & James in Miami - Midas Letter 119
Liberty Health Sciences Inc (CNSX:LHS) CEO on Aphria Inc (TSE:APH) Divestiture Lock-up
Liberty Health Sciences Inc’s (CNSX:LHS) Success in Florida Market